| Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis V Oliva, M Lippi, R Paci, L Del Fabro, G Delvecchio, P Brambilla, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, 110266, 2021 | 80 | 2021 |
| The influence of the serotonin transporter gene 5-HTTLPR polymorphism on suicidal behaviors: a meta-analysis G Fanelli, A Serretti Progress in Neuro-Psychopharmacology and Biological Psychiatry 88, 375-387, 2019 | 64 | 2019 |
| Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders G Fanelli, B Franke, W De Witte, IH Ruisch, J Haavik, V van Gils, ... Translational psychiatry 12 (1), 59, 2022 | 49 | 2022 |
| Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder G Fanelli, F Benedetti, S Kasper, J Zohar, D Souery, S Montgomery, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 108, 110170, 2021 | 42 | 2021 |
| A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response G Fanelli, K Domschke, A Minelli, M Gennarelli, P Martini, M Bortolomasi, ... European Neuropsychopharmacology 55, 86-95, 2022 | 24* | 2022 |
| A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans A Rampino, P Taurisano, G Fanelli, M Attrotto, S Torretta, LA Antonucci, ... European Neuropsychopharmacology 27 (9), 928-939, 2017 | 23 | 2017 |
| Temporally ordered associations between type 2 diabetes and brain disorders–a Danish register-based cohort study T Wimberley, HT Horsdal, I Brikell, TM Laursen, A Astrup, G Fanelli, ... BMC psychiatry 22 (1), 573, 2022 | 21 | 2022 |
| Depression, antidepressants, and insulin resistance: which link? G Fanelli, A Serretti European neuropsychopharmacology: the journal of the European College of …, 2022 | 17 | 2022 |
| The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries G Fugger, L Bartova, C Fabbri, G Fanelli, M Dold, MMM Swoboda, ... European archives of psychiatry and clinical neuroscience 272 (4), 715-727, 2022 | 17 | 2022 |
| Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts V Oliva, G Fanelli, S Kasper, J Zohar, D Souery, S Montgomery, D Albani, ... International clinical psychopharmacology 37 (2), 38-45, 2022 | 16 | 2022 |
| Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression G Fanelli, F Benedetti, SM Wang, SJ Lee, TY Jun, PS Masand, AA Patkar, ... Journal of Affective Disorders 249, 410-417, 2019 | 16 | 2019 |
| The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review G Fanelli, NR Mota, J Salas-Salvadó, M Bullo, F Fernandez-Aranda, ... Neuroscience & Biobehavioral Reviews 143, 104927, 2022 | 15 | 2022 |
| Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses C Possidente, G Fanelli, A Serretti, C Fabbri Neuroscience & Biobehavioral Reviews, 105298, 2023 | 12 | 2023 |
| Machine learning prediction of comorbid substance use disorders among people with bipolar disorder V Oliva, M De Prisco, MT Pons-Cabrera, P Guzmán, G Anmella, ... Journal of Clinical Medicine 11 (14), 3935, 2022 | 11 | 2022 |
| Clinical specificity profile for novel rapid acting antidepressant drugs M Scala, G Fanelli, D De Ronchi, A Serretti, C Fabbri International Clinical Psychopharmacology 38 (5), 297-328, 2023 | 10 | 2023 |
| Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database C Kraus, A Kautzky, V Watzal, A Gramser, B Kadriu, ZD Deng, L Bartova, ... Journal of affective disorders 335, 349-357, 2023 | 10 | 2023 |
| The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation? M Lippi, G Fanelli, C Fabbri, D De Ronchi, A Serretti International Clinical Psychopharmacology 37 (6), 263-275, 2022 | 10 | 2022 |
| Epigenetic basis of psychiatric disorders: a narrative review F Panariello, G Fanelli, C Fabbri, AR Atti, D De Ronchi, A Serretti CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 10 | 2022 |
| The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis G Fico, V Oliva, M De Prisco, A Gimenez-Palomo, M Sague-Vilavella, ... European Neuropsychopharmacology 60, 55-75, 2022 | 9 | 2022 |
| Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly G Fanelli, F Benedetti, SM Wang, SJ Lee, TY Jun, PS Masand, AA Patkar, ... European Archives of Psychiatry and Clinical Neuroscience 270, 901-910, 2020 | 9 | 2020 |
Alessandro SerrettiProfessor of Psychiatry, Kore University of EnnaVerified email at unikore.it
